Sorbonne Universite
157 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 9 name spellings.
3
Ending by 2030
Oct 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 21, 2026The maintenance fee for Use of Low Dose IL-2 for Treating Autoimmune Related or Inflammatory Disorders (US 10,293,028) comes due Nov 21, 2026. Unpaid by May 21, 2027, it lapses early.
- 7 fees due Dec 6 to 27, 2026 · next Dec 6
- 3 fees due Jan 14 to 21, 2027 · next Jan 14
- 6 fees due Feb 1 to 28, 2027 · next Feb 1
- 1 fee due Apr 3, 2027The maintenance fee for Implantable Ultrasound Generating Treating Device for Spinal Cord And/Or Spinal Nerve Treatment, Apparatus Comprising Such Device and Method (US 11,771,925) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
- 2 fees due May 5 to 12, 2027 · next May 5
- 3 fees due Jun 10 to 24, 2027 · next Jun 10
- 5 fees due Jul 2 to 16, 2027 · next Jul 2
- 3 fees due Aug 11 to 20, 2027 · next Aug 11
- 2 fees due Sep 1 to 24, 2027 · next Sep 1
- 2 fees due Oct 9 to 16, 2027 · next Oct 9
Recent changes
- 10 of the patents on this record were granted since Aug 21, 2026
- Nov 17 US 12,802,837 Compact Magneto-Optical Trap with Thermal Ablation
- Nov 17 US 12,800,459 Apparatus for Detecting Chemicals in a Sample
- Nov 10 US 12,788,777 Genetically Modified Human Stem Cell Expressing a Mutant Human Cytochrome P450 2B6 Protein and Use Thereof in the Treatment of Cancer
- Nov 3 US 12,781,178 Structuring a Set of Objects Such as Cells and Micron-Sized Particles Using Acoustic Force
- Oct 13 US 12,762,460 Method and Server for Delegated Quantum Computing Using a Hardware Enclave
- Oct 13 US 12,759,075 Device for Controlling the Axial Position of a Laser Focal Point Produced by a Microscope Objective
- Oct 13 US 12,758,592 Magnetic Bacteria, Non-Therapeutic and Therapeutic Uses Thereof
- Sep 22 US 12,740,789 Medical Devices and Methods for Penetrating an Anatomical Structure Based on Sensed Electrical Characteristics
- Sep 1 US 12,723,267 Method for Inducing Targeted Meiotic Recombinations
- Aug 25 US 12,717,019 Device and Method for Centimetre-Level Positioning of a Moving Object
- 5 terms have ended since Aug 21, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,932,422 | Use of Chlorine Guanabenz Derivatives for Treating Polyglutamine Expansion Associated Diseases In force · High confidence | In force | High confidence | |
| US 7,897,044 | Fluid Separation Device In force · High confidence | In force | High confidence | |
| US 10,465,191 | Tricyclo-DNA Antisense Oligonucleotides, Compositions, and Methods for the Treatment of Disease In force · High confidence | In force | High confidence | |
| US 9,080,170 | Modified U7 Snrnas for Treatment of Neuromuscular Diseases In force · High confidence | In force | High confidence | |
| US 8,961,499 | Surgical Instrument In force · High confidence | In force | High confidence | |
| US 9,662,357 | Novel Bacterium and Extracts of Said Bacterium and the Use of Same in Dermatology In force · High confidence | In force | High confidence | |
| US 9,084,811 | Novel Bacterium and Extracts of Said Bacterium and the Use of Same in Dermatology In force · High confidence | In force | High confidence | |
| US 10,765,723 | Use of Low Dose IL-2 for Treating Autoimmune - Related or Inflammatory Disorders In force · High confidence | In force | High confidence | |
| US 11,559,566 | Use of Low Dose IL-2 for Treating Autoimmune-Related or Inflammatory In force · High confidence | In force | High confidence | |
| US 12,491,232 | Low Dose IL-2 for Treating Autoimmune-Related or Inflammatory Disorders In force · High confidence | In force | High confidence |
Also on record, not counted in the 156: 157 patents in force now held by others · 43 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
142 pending · 112 abandoned · 3 no status recorded